![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ![]() Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | ||
Founding Date | Founding Date 1863 | Founding Date 1999 | Founding Date 1886 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | |
Employees | Employees 88,5021% decrease | Employees 94,300 | Employees 138,1005% increase |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 2.7 b | Valuation ($) 396.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $94.2b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods $30.3b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit $63.9b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income $26.8b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries 83 (FY, 2021) | Countries 130 (FY, 2021) | Countries N/A |
Funding | |||
Total funding raised | Total funding raised $ 3.5b | Total funding raised $ 1b | Total funding raised N/A |

AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View company